the use of targeted drug therapy for aggressive lymphoma
Published 2 weeks ago • 38 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
2:08
cellular and targeted therapies for hodgkin lymphoma
-
4:06
lymphoma cellular therapy update
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
5:45
the most bio-available curcumin formulas for multiple myeloma
-
11:47
petscan results. warning...not what we hoped for.
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
5:21
chemo-free regimens in lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
3:02
the role of asparaginase in the treatment of all
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:28
updates on targeted therapy in the treatment of myeloma